Amadeus Capital Partners — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
Ori develops expandable-unit technology for multifamily real estate, enabling hotel-to-housing conversions and ground-up developments that increase unit density while maintaining livability.
Construction TechHardwareImpact & Social GoodPropTech
Co-investorsIngka InvestmentsPresidio VenturesThe E14 FundDelin VenturesKhosla VenturesNorthpond Ventures+3 more
ORI provides an integrated business planning platform for supply chain professionals, combining demand planning, S&OP, S&OE, data analytics, and long-term planning in one tool.
AI & Machine LearningLogistics & Supply ChainSaaS
Brant Slade(Founder)in
Co-investorsKickstartDelin VenturesKhosla VenturesNorthpond VenturesNovalis LifeSciencesOctopus Ventures+2 more
Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical Devices
Co-investorsKindred CapitalNovalis LifeSciencesDelin VenturesNorthpond VenturesOctopus VenturesPuhua Capital
V7 develops AI systems that combine machine efficiency with human expertise for visual and document-based decision-making, offering tools for data labeling, model training, and AI-driven knowledge work across fields like medicine, engineering, and finance.
AI & Machine LearningEnterprise SoftwareFintechSaaSLondon, GB
Co-investorsAir Street CapitalAFG PartnersAmadeus Capital SARadical VenturesTemasek
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.